GO:0043404 corticotropin-releasing hormone receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043404 (corticotropin-releasing hormone receptor activity) is a molecular function defined as combining with corticotropin-releasing hormone and transmitting the signal to initiate a change in cell activity.
• The two principal receptors carrying this activity are CRHR1 and CRHR2, which are G protein-coupled receptors that mediate stress-related neuroendocrine, cardiovascular, and metabolic responses.
• CRH-CRHR1 signaling has been linked to gut dysbiosis under stress, with mitochondrial pathways as downstream effectors.
• CRHR2 is implicated in pressure overload-induced cardiac dysfunction and in sex-differential regulation of cold-evoked eating behavior.
• Genetic variation in CRHR1 and CRHR2 has been associated with polycystic ovary syndrome in human linkage and association studies.
• CRHR1 neurons can be targeted using transgenic tools such as Crhr1-FlpO mice, enabling circuit-level and behavioral studies.
Description
Corticotropin-releasing hormone receptor activity (GO:0043404) is the molecular function by which a receptor binds corticotropin-releasing hormone (CRH) and converts that binding event into an intracellular signal that changes cell behavior. This activity is central to the hypothalamic-pituitary-adrenal axis and to extrahypothalamic stress circuits, and it is carried out primarily by the G protein-coupled receptors CRHR1 and CRHR2. Because CRH signaling coordinates endocrine, behavioral, cardiovascular, and immune responses, the receptors that execute GO:0043404 are studied across neuroendocrinology, cardiology, metabolism, and reproductive biology. At the cellular level, corticotropin-releasing hormone receptor activity is not a single downstream pathway but a signaling hub. Activation of CRHR1 or CRHR2 engages G protein-dependent cascades that alter neuronal excitability, hormone release, and metabolic gene programs. Recent work has extended this function beyond the classical stress axis: CRH-CRHR1 signaling can trigger gut dysbiosis through mitochondrial pathways, and central CRHR2 participates in sex-differential control of cold-evoked eating. These findings make GO:0043404 a relevant annotation for researchers asking how stress-related ligands produce cell-type-specific outcomes. For experimental biologists, GO:0043404 provides a precise functional label for assays that measure CRH binding and CRH-evoked signal transduction. It distinguishes the receptor activity itself from downstream processes such as cortisol synthesis or behavioral output, and it helps organize genetic models, pharmacological tools, and transcriptomic data around a defined molecular function.
corticotropin-releasing hormone receptor activity At A Glance
| GO ID | GO:0043404 |
|---|---|
| GO term | corticotropin-releasing hormone receptor activity |
| Ontology | molecular_function |
| Synonym | adrenocorticotropin-releasing hormone receptor activity; corticotropin releasing factor receptor activity; CRF receptor activity; CRH receptor activity |
| Definition | Combining with corticotropin-releasing hormone and transmitting the signal to initiate a change in cell activity. |
| Major function | CRH binding and signal transduction through CRH receptors |
| Representative receptors | CRHR1 and CRHR2 |
| Related ligand | Corticotropin-releasing hormone (CRH) |
| Research areas | Stress neurobiology, cardiovascular biology, metabolism, reproduction, gut physiology |
What Is GO:0043404?
In plain terms, GO:0043404 describes what a CRH receptor does: it combines with corticotropin-releasing hormone and transmits the signal to initiate a change in cell activity. The QuickGO definition captures both the binding event and the signaling consequence, so the term is assigned when a gene product acts as a receptor for CRH and couples that recognition to an intracellular response. Synonyms include adrenocorticotropin-releasing hormone receptor activity, corticotropin releasing factor receptor activity, CRF receptor activity, and CRH receptor activity.
Why Is corticotropin-releasing hormone receptor activity Important in Cell Biology?
GO:0043404 matters because CRH receptor activity is a proximal control point for stress-related physiology and for multiple disease-relevant processes. The receptors that carry this activity, CRHR1 and CRHR2, are expressed in brain circuits, the cardiovascular system, and peripheral tissues, where they translate CRH signals into changes in neuronal activity, cardiac function, and metabolic behavior. Because the same molecular function can produce different outcomes depending on cell type and receptor subtype, precise annotation of GO:0043404 supports mechanistic studies of stress, inflammation, and organ dysfunction.
• Defines the receptor activity that initiates CRH-dependent cellular responses.
• Underlies hypothalamic-pituitary-adrenal axis control of stress hormone release.
• Links stress to gut dysbiosis through CRH-CRHR1-mitochondria signaling.
• Contributes to pressure overload-induced cardiac dysfunction via CRHR2.
• Is associated with polycystic ovary syndrome through CRHR1 and CRHR2 variants.
• Participates in sex-differential regulation of cold-evoked eating behavior.
• Enables circuit-level dissection using Crhr1-FlpO transgenic mice.
• Provides a target for pharmacological modulation of CRHR1 neurons and ethanol drinking.
• Supports comparative studies of stress responses in zebrafish.
• Offers a defined molecular function for CRISPR-based validation of receptor genes.
Molecular Mechanism of corticotropin-releasing hormone receptor activity
Ligand recognition and receptor binding
In simple terms: The receptor first grabs the CRH signal molecule.
Corticotropin-releasing hormone receptor activity begins when a CRH receptor binds corticotropin-releasing hormone. This binding event is the defining feature of GO:0043404, which requires combining with CRH before transmitting a signal. The two major receptors annotated with this activity are CRHR1 and CRHR2, which are G protein-coupled receptors that recognize CRH family ligands. Receptor subtype identity influences where and when this binding occurs, as shown by studies of CRH family receptors in the cardiovascular system and by work on CRHR1 neurons in stress-related circuits.
Signal transduction to intracellular effectors
In simple terms: Once CRH is bound, the receptor flips a switch inside the cell.
After ligand binding, the receptor transmits the signal to initiate a change in cell activity. This transduction step is what distinguishes receptor activity from simple ligand sequestration. CRH receptor signaling has been linked to mitochondrial pathways in the gut, where stress triggers dysbiosis via CRH-CRHR1-mitochondria signaling. In the cardiovascular system, CRH family receptors participate in signaling that affects cardiac function, and CRHR2 antagonism can prevent pressure overload-induced cardiac dysfunction. These examples show that the signal transmitted by GO:0043404 can engage diverse intracellular effectors depending on tissue context.
Receptor subtype diversity: CRHR1 and CRHR2
In simple terms: Two related receptors do the same job but in different places and ways.
CRHR1 and CRHR2 both carry corticotropin-releasing hormone receptor activity, but they differ in expression pattern and downstream effects. CRHR1 neurons have been targeted with transgenic tools to study stress and reward circuits, including a Crhr1-FlpO mouse line validated for specificity. Central CRHR2 has been implicated in sex-differential regulation of cold-evoked eating behavior, and a CRHR2 antagonist has been tested for prevention of pressure overload-induced cardiac dysfunction. Genetic association studies have linked both CRHR1 and CRHR2 to polycystic ovary syndrome, indicating that subtype-specific functions of GO:0043404 are relevant to human traits.
Regulation by pharmacological and genetic tools
In simple terms: Scientists can turn this receptor activity up or down with drugs and mutations.
Corticotropin-releasing hormone receptor activity is regulatable by small molecules and genetic manipulations. The psychedelic psilocin suppresses activity of central amygdala CRHR1 neurons and decreases ethanol drinking in female mice, demonstrating that receptor activity can be modulated in vivo. A CRHR2 antagonist, RQ-00490721, has been studied for prevention of pressure overload-induced cardiac dysfunction. In zebrafish, CRHR1 mediates enhanced locomotor activity and metabolic demands to acute thermal stress, providing a comparative model for testing how this activity is regulated across species.
Integration with stress and metabolic physiology
In simple terms: This receptor activity is a hub that connects stress to whole-body physiology.
GO:0043404 sits at the interface of stress signaling and organismal physiology. CRH family receptors in the cardiovascular system contribute to cardiac responses to stress, while central CRHR2 participates in feeding behavior under cold stress. Stress-induced gut dysbiosis via CRH-CRHR1-mitochondria signaling shows that receptor activity can reshape microbial communities. Together, these findings indicate that corticotropin-releasing hormone receptor activity is not an isolated molecular event but a node that integrates neuroendocrine, metabolic, and peripheral signals.
Key Genes Involved in GO:0043404 corticotropin-releasing hormone receptor activity
The genes most directly associated with GO:0043404 encode CRH receptors and related signaling components studied in stress, cardiovascular, metabolic, and reproductive biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CRHR1 | Primary receptor for CRH; carries corticotropin-releasing hormone receptor activity | Targeted in stress, gut dysbiosis, and behavioral studies |
| CRHR2 | Receptor for CRH family ligands; carries corticotropin-releasing hormone receptor activity | Studied in cardiac dysfunction, feeding behavior, and PCOS |
| CRH | Ligand that binds CRH receptors | Central to stress signaling and receptor activation |
| UCN1 | CRH family ligand | Discussed in cardiovascular CRH family receptor biology |
| UCN2 | CRH family ligand | Discussed in cardiovascular CRH family receptor biology |
| UCN3 | CRH family ligand | Discussed in cardiovascular CRH family receptor biology |
| CRHBP | CRH binding protein that modulates ligand availability | Relevant to CRH family signaling context |
| GNAs | G protein alpha subunit involved in GPCR signaling | General downstream context for CRH receptor signaling |
| POMC | Pro-opiomelanocortin, downstream of CRH receptor activation in HPA axis | Classical stress axis readout |
| NR3C1 | Glucocorticoid receptor, downstream of HPA axis activation | Feedback regulation of stress axis |
| BDNF | Neurotrophic factor linked to stress circuits | Studied in CRHR1 neuron contexts |
| GAD1 | GABA synthesis enzyme in inhibitory neurons | Relevant to CRHR1 neuron circuit studies |
| GAD2 | GABA synthesis enzyme in inhibitory neurons | Relevant to CRHR1 neuron circuit studies |
| SLC17A7 | Vesicular glutamate transporter | Marker for excitatory neurons in CRHR1 circuit studies |
| TH | Tyrosine hydroxylase, catecholamine synthesis | Relevant to stress and reward circuit studies |
| CRHR1-FlpO | Transgenic allele for targeting CRHR1 neurons | Validated tool for circuit-specific manipulation |
| CRHR2 antagonist target | Pharmacological target for CRHR2 activity | Tested in cardiac dysfunction models |
| CRH-CRHR1-mitochondria axis | Signaling pathway linking stress to gut dysbiosis | Studied in microbiome and stress research |
How Is corticotropin-releasing hormone receptor activity Regulated?
Corticotropin-releasing hormone receptor activity is regulated at multiple levels, including ligand availability, receptor subtype expression, and pharmacological modulation. CRH family ligands and their receptors are expressed in the cardiovascular system, where they influence cardiac responses. Small-molecule modulation can suppress CRHR1 neuron activity, as shown by psilocin effects on central amygdala CRHR1 neurons and ethanol drinking. CRHR2 can be blocked by antagonists such as RQ-00490721 in pressure overload models. Genetic tools such as Crhr1-FlpO mice allow selective targeting of CRHR1-expressing cells for functional studies. In zebrafish, CRHR1 mediates locomotor and metabolic responses to acute thermal stress, indicating conserved regulation of this activity.
corticotropin-releasing hormone receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CRHR1 | Stress-induced gut dysbiosis | CRHR1 knockout or knockdown in gut epithelium models |
| CRHR2 | Pressure overload-induced cardiac dysfunction | CRHR2 antagonist treatment in cardiac overload models |
| CRHR1/CRHR2 | Polycystic ovary syndrome | Genetic association and linkage models |
| CRHR2 | Cold-evoked eating behavior | Central CRHR2 manipulation in feeding studies |
| CRHR1 | Ethanol drinking behavior | CRHR1 neuron modulation in female mice |
Stress-related gut dysbiosis
Stress can trigger gut dysbiosis via CRH-CRHR1-mitochondria signaling, linking corticotropin-releasing hormone receptor activity to microbiome composition and intestinal function. This connection suggests that GO:0043404 is relevant to stress-associated gastrointestinal conditions and to studies of the gut-brain axis.
Cardiovascular dysfunction
CRH family receptors are expressed in the cardiovascular system, and a CRHR2 antagonist has been studied for prevention of pressure overload-induced cardiac dysfunction. These findings place corticotropin-releasing hormone receptor activity in the context of cardiac stress responses and heart failure research.
Polycystic ovary syndrome
Novel CRHR1 and CRHR2 genes show linkage to and association with polycystic ovary syndrome, indicating that genetic variation affecting corticotropin-releasing hormone receptor activity may contribute to reproductive and metabolic phenotypes.
Stress-related behavior and alcohol drinking
Central amygdala CRHR1 neurons are suppressed by psilocin, which decreases ethanol drinking in female mice, linking receptor activity to stress-related drinking behavior. Central CRHR2 also participates in sex-differential regulation of cold-evoked eating behavior, showing that GO:0043404 contributes to behavioral and metabolic control.
From corticotropin-releasing hormone receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CRHR1 mediate stress-induced gut dysbiosis? | CRHR1 knockout or conditional KO in gut models |
| Can CRHR2 antagonism prevent cardiac dysfunction? | CRHR2 point-mutation or pharmacological blockade in pressure overload models |
| Are CRHR1/CRHR2 variants associated with PCOS? | Knock-in of human variants in cell or animal models |
| How does central CRHR2 regulate feeding? | CRHR2 knockout or overexpression in hypothalamic circuits |
| Can CRHR1 neurons be selectively targeted? | Crhr1-FlpO transgenic knock-in for circuit manipulation |
| Does CRHR1 activity drive ethanol drinking? | CRHR1 overexpression or KO in central amygdala neurons |
How to Study the corticotropin-releasing hormone receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRHR1-FlpO transgenic targeting | Selective manipulation of CRHR1 neurons | Circuit-level studies of stress and reward |
| CRHR2 antagonist treatment | Pharmacological blockade of CRHR2 activity | Cardiac dysfunction prevention studies |
| Genetic association/linkage | Variant-disease relationships for CRHR1/CRHR2 | PCOS genetics |
| Behavioral feeding assays | Cold-evoked eating behavior | Central CRHR2 function |
| Ethanol drinking paradigms | Alcohol consumption after CRHR1 modulation | Stress-related drinking studies |
| Microbiome sequencing | Gut microbial composition | Stress-induced dysbiosis via CRH-CRHR1 |
| Zebrafish thermal stress assay | Locomotor activity and metabolic demand | Comparative CRHR1 function |
| Cardiovascular expression profiling | CRH family receptor expression in heart | Cardiac stress biology |
Genetic and transgenic targeting
Transgenic tools such as Crhr1-FlpO mice allow selective targeting of CRHR1-expressing neurons, enabling circuit-level studies of corticotropin-releasing hormone receptor activity. Knockout and knock-in models can test the causal role of CRHR1 or CRHR2 in stress-related phenotypes.
Pharmacological modulation
Small molecules and antagonists can acutely modulate receptor activity. Psilocin suppresses central amygdala CRHR1 neuron activity and decreases ethanol drinking in female mice, while the CRHR2 antagonist RQ-00490721 has been tested in pressure overload-induced cardiac dysfunction. These approaches complement genetic models by providing temporal control.
Behavioral and physiological assays
Corticotropin-releasing hormone receptor activity can be inferred from behavioral and physiological outputs. Cold-evoked eating behavior is regulated by central CRHR2 in a sex-differential manner, and CRHR1 mediates locomotor activity and metabolic demands to acute thermal stress in zebrafish. These assays link molecular function to organismal responses.
Microbiome and mitochondrial readouts
Stress-induced gut dysbiosis via CRH-CRHR1-mitochondria signaling can be studied with microbiome sequencing and mitochondrial function assays. Such readouts connect corticotropin-releasing hormone receptor activity to microbial ecology and cellular metabolism.
How CRISPR Can Be Used to Study GO:0043404 corticotropin-releasing hormone receptor activity
Knockout
CRISPR knockout of CRHR1 or CRHR2 can remove corticotropin-releasing hormone receptor activity and test its requirement in stress-related phenotypes such as gut dysbiosis or cardiac dysfunction. Knockout models are useful for validating whether a receptor subtype is necessary for a given CRH-dependent response.
Point Mutation
Point mutations can be introduced into CRHR1 or CRHR2 to dissect ligand binding or signaling domains, or to model human variants associated with conditions such as polycystic ovary syndrome. Such edits help separate binding from downstream signal transmission within GO:0043404.
Knock-in
Knock-in of reporter or transgenic alleles, such as Crhr1-FlpO, enables selective targeting of CRHR1-expressing cells and validation of receptor-specific circuits. Knock-in of human disease-associated variants can also create more faithful models of receptor activity changes.
Overexpression
Overexpression of CRHR1 or CRHR2 can amplify corticotropin-releasing hormone receptor activity to test sufficiency in behavioral or physiological outcomes, such as ethanol drinking or feeding behavior. Overexpression models complement knockout approaches by probing gain-of-function effects.
How EDITGENE Supports corticotropin-releasing hormone receptor activity Research
Researchers studying corticotropin-releasing hormone receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific stress, cardiac, or metabolic phenotype. CRISPR-based models provide a direct way to test necessity and sufficiency of CRHR1, CRHR2, and related signaling components in relevant cell types and organisms.
Contact EDITGENE today to design your custom CRISPR model for corticotropin-releasing hormone receptor activity research.
Frequently Asked Questions About corticotropin-releasing hormone receptor activity
What is corticotropin-releasing hormone receptor activity?
It is the molecular function defined by GO:0043404, in which a receptor combines with corticotropin-releasing hormone and transmits the signal to initiate a change in cell activity.
What genes are involved in corticotropin-releasing hormone receptor activity?
The principal genes are CRHR1 and CRHR2, which encode G protein-coupled receptors for CRH family ligands.
What is the GO ID for corticotropin-releasing hormone receptor activity?
The GO ID is GO:0043404.
Which ontology does GO:0043404 belong to?
GO:0043404 belongs to the molecular_function ontology.
What are synonyms for corticotropin-releasing hormone receptor activity?
Synonyms include adrenocorticotropin-releasing hormone receptor activity, corticotropin releasing factor receptor activity, CRF receptor activity, and CRH receptor activity.
How is CRHR1 involved in stress-related disease?
CRH-CRHR1 signaling can trigger gut dysbiosis via mitochondrial pathways, and CRHR1 neurons are studied in stress and ethanol drinking behavior.
What is the role of CRHR2 in the heart?
A CRHR2 antagonist has been studied for prevention of pressure overload-induced cardiac dysfunction, and CRH family receptors are expressed in the cardiovascular system.
Are CRHR1 and CRHR2 associated with polycystic ovary syndrome?
Yes, novel CRHR1 and CRHR2 genes show linkage to and association with polycystic ovary syndrome.
How can researchers study corticotropin-releasing hormone receptor activity?
Approaches include transgenic targeting such as Crhr1-FlpO mice, pharmacological modulation, behavioral assays, and microbiome or mitochondrial readouts.
Can CRISPR be used to model CRHR1 or CRHR2 function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test necessity and sufficiency of corticotropin-releasing hormone receptor activity in stress, cardiac, and metabolic contexts.
Conclusion
GO:0043404, corticotropin-releasing hormone receptor activity, defines the molecular function by which CRH receptors bind corticotropin-releasing hormone and transmit a signal that changes cell activity. The receptors CRHR1 and CRHR2 carry this activity and connect stress signaling to gut physiology, cardiovascular function, feeding behavior, and reproductive traits. Because this activity sits at the top of diverse downstream pathways, it is a productive target for CRISPR-based functional studies. Knockout, point-mutation, knock-in, and overexpression models allow researchers to test how CRHR1 and CRHR2 contribute to disease-relevant phenotypes and to identify modifiers of corticotropin-releasing hormone receptor activity.
References
- 1. Zhang Y et al.. 2024. Stress triggers gut dysbiosis via CRH-CRHR1-mitochondria pathway.. NPJ Biofilms Microbiomes 10(1):93 PMID: 39349483
- 2. Mori Y et al.. 2022. Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction.. Biomed Pharmacother 146:112566 PMID: 34954642
- 3. Amin M et al.. 2023. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.. J Ovarian Res 16(1):155 PMID: 37543650
- 4. Zhou Y et al.. 2025. Central corticotropin releasing hormone receptor 2 may participate in sex differential regulation of cold-evoked eating behavior.. Neuroscience 566:169-176 PMID: 39733820
- 5. Hardy M et al.. 2024. Targeting corticotropin-releasing hormone receptor type 1 (Crhr1) neurons: validating the specificity of a novel transgenic Crhr1-FlpO mouse.. Brain Struct Funct 230(1):12 PMID: 39692887
- 6. Magee SN et al.. 2025. The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice.. J Neurosci 45(50) PMID: 41213805
- 7. Takefuji M et al.. 2019. Corticotropin-Releasing Hormone Family and Their Receptors in the Cardiovascular System.. Circ J 83(2):261-266 PMID: 30584229
- 8. Shvartsburd Z et al.. 2025. Corticotropin-releasing hormone receptor 1 mediates the enhanced locomotor activity and metabolic demands to an acute thermal stress in adult zebrafish.. J Neuroendocrinol 37(4):e13497 PMID: 39915694
